FDA Approval

Event · Clinical & Scientific

Displaying items 221-222 of 222 in total

Innovation Spotlight: The Future of Business 4 months ago

Syndax's Revuforj Rewrites the Playbook for Leukemia Treatment

New data reveals Syndax's Revuforj is a game-changer for leukemia, sparking a battle for market dominance in targeted cancer therapy.

Read full article
Syndax's Revuforj Rewrites the Playbook for Leukemia Treatment
Margaret Mitchell: Unfiltered 4 months ago

The Echosens Blueprint: A Top Workplace as a Growth Engine

How does a MedTech firm win 'Top Workplace' twice? Echosens proves that a mission-driven culture is the ultimate catalyst for innovation and market leadership.

Read full article
The Echosens Blueprint: A Top Workplace as a Growth Engine

Related topics in Clinical & Scientific

Breakthrough DesignationCE MarkClinical Trial397Drug Application1Phase 1/2/322Scientific Publication11